Sangamo Therapeutics (SGMOQ) Receivables - Other (2010 - 2024)
Sangamo Therapeutics (SGMOQ) posted quarterly Receivables - Other of $10.0 million for Q3 2024, up 1561.13% year-over-year from $602000.0 in Q4 2023, and up 2381.39% quarter-over-quarter from $403000.0 in Q4 2023.
Sangamo Therapeutics (SGMOQ) Receivables - Other (2010 - 2024) Analysis & Trends
Sangamo Therapeutics' Receivables - Other history runs 15 years deep, the most recent figure standing at $10.0 million for Q3 2024.
- In Q3 2024, Receivables - Other rose 1561.13% year-over-year to $10.0 million; the TTM figure through Sep 2024 stood at $10.0 million (up 1561.13% YoY), while the FY2023 annual figure was $403000.0, down 49.24% from the prior year.
- Receivables - Other for Q3 2024 stood at $10.0 million, up from $403000.0 in the prior quarter.
- The five-year high for Receivables - Other was $10.0 million in Q3 2024, with the low at $289000.0 in Q2 2022.
- The 5-year median for Receivables - Other is $794000.0 (2022), against an average of $1.3 million.
- The sharpest annual moves came in 2021 and 2024: Receivables - Other tumbled 66.28% in 2021, then jumped 1561.13% in 2024.
- Sangamo Therapeutics' Receivables - Other stood at $1.0 million in 2020, then tumbled by 66.28% to $349000.0 in 2021, then soared by 127.51% to $794000.0 in 2022, then sank by 49.24% to $403000.0 in 2023, then soared by 2381.39% to $10.0 million in 2024.
- Business Quant data shows SGMOQ's Receivables - Other at $10.0 million in Q3 2024, $403000.0 in Q4 2023, and $602000.0 in Q3 2023.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 10.00 Mn |
| Sep 30, 2024 | 10.00 Mn |
| Dec 31, 2023 | 403,000.00 |
| Dec 31, 2023 | 403,000.00 |
| Sep 30, 2023 | 602,000.00 |
| Sep 30, 2023 | 602,000.00 |
| Jun 30, 2023 | 1.22 Mn |
| Jun 30, 2023 | 1.22 Mn |
| Mar 31, 2023 | 1.02 Mn |
| Mar 31, 2023 | 1.02 Mn |
| Dec 31, 2022 | 794,000.00 |
| Dec 31, 2022 | 794,000.00 |
| Sep 30, 2022 | 524,000.00 |
| Sep 30, 2022 | 524,000.00 |
| Jun 30, 2022 | 289,000.00 |
| Jun 30, 2022 | 289,000.00 |
| Mar 31, 2022 | 356,000.00 |
| Mar 31, 2022 | 356,000.00 |
| Dec 31, 2021 | 349,000.00 |
| Dec 31, 2021 | 349,000.00 |